313 related articles for article (PubMed ID: 26662852)
1. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice.
Tosello-Trampont AC; Krueger P; Narayanan S; Landes SG; Leitinger N; Hahn YS
Hepatology; 2016 Mar; 63(3):799-812. PubMed ID: 26662852
[TBL] [Abstract][Full Text] [Related]
2. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
3. Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment.
Fan Y; Zhang W; Wei H; Sun R; Tian Z; Chen Y
Liver Int; 2020 Mar; 40(3):598-608. PubMed ID: 31758647
[TBL] [Abstract][Full Text] [Related]
4. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
[TBL] [Abstract][Full Text] [Related]
5. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.
Hart KM; Fabre T; Sciurba JC; Gieseck RL; Borthwick LA; Vannella KM; Acciani TH; de Queiroz Prado R; Thompson RW; White S; Soucy G; Bilodeau M; Ramalingam TR; Arron JR; Shoukry NH; Wynn TA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659437
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
[TBL] [Abstract][Full Text] [Related]
8. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
[TBL] [Abstract][Full Text] [Related]
9. NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.
Gur C; Doron S; Kfir-Erenfeld S; Horwitz E; Abu-Tair L; Safadi R; Mandelboim O
Gut; 2012 Jun; 61(6):885-93. PubMed ID: 22198715
[TBL] [Abstract][Full Text] [Related]
10. Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.
Jeong WI; Park O; Suh YG; Byun JS; Park SY; Choi E; Kim JK; Ko H; Wang H; Miller AM; Gao B
Hepatology; 2011 Apr; 53(4):1342-51. PubMed ID: 21480338
[TBL] [Abstract][Full Text] [Related]
11. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
14. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
15. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
16. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
[TBL] [Abstract][Full Text] [Related]
18. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
[TBL] [Abstract][Full Text] [Related]
19. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
[TBL] [Abstract][Full Text] [Related]
20. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Heinrichs D; Brandt EF; Fischer P; Köhncke J; Wirtz TH; Guldiken N; Djudjaj S; Boor P; Kroy D; Weiskirchen R; Bucala R; Wasmuth HE; Strnad P; Trautwein C; Bernhagen J; Berres ML
Cells; 2021 Jan; 10(2):. PubMed ID: 33525493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
